Loading…

A single dose sub-unit vaccine protects against pneumonic plague

In this study, the protection afforded against aerosolised Yersinia pestis by injection of a single dose of an alhydrogel-adsorbed sub-unit vaccine has been compared with that given by an existing killed whole cell vaccine licensed for human use. The sub-unit vaccine, prepared by admixing F1 antigen...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2000-10, Vol.19 (4), p.566-571
Main Authors: Williamson, E.Diane, Eley, Steven M., Stagg, Anthony J., Green, Michael, Russell, Paul, Titball, Richard W.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c420t-d3c20edd38ad507422b328e78aac14f31cbc6e1f9d2d603b998f8c9a6ddfc6bb3
cites
container_end_page 571
container_issue 4
container_start_page 566
container_title Vaccine
container_volume 19
creator Williamson, E.Diane
Eley, Steven M.
Stagg, Anthony J.
Green, Michael
Russell, Paul
Titball, Richard W.
description In this study, the protection afforded against aerosolised Yersinia pestis by injection of a single dose of an alhydrogel-adsorbed sub-unit vaccine has been compared with that given by an existing killed whole cell vaccine licensed for human use. The sub-unit vaccine, prepared by admixing F1 antigen derived from a Y. pestis cell culture supernatant with recombinant V antigen derived from an E. coli cell lysate, fully protected an outbred strain of mouse against exposure to 10 6 CFU of virulent plague organisms (10 4 mouse lethal doses, MLD). In contrast, the whole cell vaccine provided only 16% protection against the same level of challenge. Furthermore, sub-unit vaccinees were able to clear the bacteria from their lungs post-challenge whereas bacteria were cultured from the lungs of a surviving KWC vaccinee post-challenge. In killed whole cell vaccinees, physiologically significant levels of IgG to F1 only were detectable and the levels of F1-specific IgG in serum and in broncho-alveolar washings were significantly lower ( p
doi_str_mv 10.1016/S0264-410X(00)00159-6
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72330839</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X00001596</els_id><sourcerecordid>72330839</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-d3c20edd38ad507422b328e78aac14f31cbc6e1f9d2d603b998f8c9a6ddfc6bb3</originalsourceid><addsrcrecordid>eNqF0E1LxDAQgOEgiq4fP0EpCKKH6iRp0_Ski_gFggcVvIV0Ml0i3XRtWsF_b9dd9Ogpl2cmw8vYIYdzDlxdPINQWZpxeDsFOAPgeZmqDTbhupCpyLneZJNfssN2Y3wHgFzycpvtcA6i0EJM2NU0iT7MGkpcGymJQ5UOwffJp0X0gZJF1_aEfUzszPoQ-2QRaJi3wWOyaOxsoH22Vdsm0sH63WOvtzcv1_fp49Pdw_X0McVMQJ86iQLIOamty6HIhKik0FRoa5FnteRYoSJel044BbIqS11rLK1yrkZVVXKPnaz2jhd9DBR7M_cRqWlsoHaIphBSgpblv5AXSmZawAjzFcSujbGj2iw6P7fdl-Fglo3NT2OzDGgAzE9jo8a5o_UHQzUn9ze1jjqC4zWwEW1Tdzagj79O80IU-aguV4rGap-eOhPRU0ByvhuLG9f6fw75BicvmHY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17634820</pqid></control><display><type>article</type><title>A single dose sub-unit vaccine protects against pneumonic plague</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Williamson, E.Diane ; Eley, Steven M. ; Stagg, Anthony J. ; Green, Michael ; Russell, Paul ; Titball, Richard W.</creator><creatorcontrib>Williamson, E.Diane ; Eley, Steven M. ; Stagg, Anthony J. ; Green, Michael ; Russell, Paul ; Titball, Richard W.</creatorcontrib><description>In this study, the protection afforded against aerosolised Yersinia pestis by injection of a single dose of an alhydrogel-adsorbed sub-unit vaccine has been compared with that given by an existing killed whole cell vaccine licensed for human use. The sub-unit vaccine, prepared by admixing F1 antigen derived from a Y. pestis cell culture supernatant with recombinant V antigen derived from an E. coli cell lysate, fully protected an outbred strain of mouse against exposure to 10 6 CFU of virulent plague organisms (10 4 mouse lethal doses, MLD). In contrast, the whole cell vaccine provided only 16% protection against the same level of challenge. Furthermore, sub-unit vaccinees were able to clear the bacteria from their lungs post-challenge whereas bacteria were cultured from the lungs of a surviving KWC vaccinee post-challenge. In killed whole cell vaccinees, physiologically significant levels of IgG to F1 only were detectable and the levels of F1-specific IgG in serum and in broncho-alveolar washings were significantly lower ( p&lt;0.05) compared with sub-unit vaccinees. In sub-unit vaccinees, an IgG titre to the F1 and V antigens was detected in serum where it was significantly higher ( p&lt;0.05) compared with broncho-alveolar washings suggesting that, at the time of challenge, protection is attributable mainly to the combined circulating IgG titre to the F1 and V sub-units. The enhanced protective efficacy of this sub-unit vaccine administered as a single dose compared with an existing vaccine has been demonstrated in an outbred animal model of pneumonic plague.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/S0264-410X(00)00159-6</identifier><identifier>PMID: 11027822</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject><![CDATA[Animals ; Antibodies, Bacterial - biosynthesis ; Antibodies, Bacterial - blood ; Antigens, Bacterial - administration & dosage ; Bacterial Proteins - administration & dosage ; Bacteriology ; Biological and medical sciences ; Bronchoalveolar Lavage Fluid - immunology ; F1 antigen ; Female ; Fundamental and applied biological sciences. Psychology ; Humans ; Immunization Schedule ; Immunoglobulin G - biosynthesis ; Immunoglobulin G - blood ; Immunological correlates ; Lung - immunology ; Lung - microbiology ; Mice ; Microbiology ; Plague - immunology ; Plague - microbiology ; Plague - prevention & control ; Plague Vaccine - administration & dosage ; Pneumonic plague ; Pore Forming Cytotoxic Proteins ; Protection ; Single dose vaccine ; Spleen - immunology ; Sub-unit vaccine ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies ; Vaccines, Subunit - administration & dosage ; Yersinia pestis ; Yersinia pestis - immunology ; Yersinia pestis - isolation & purification ; Yersinia pestis - pathogenicity]]></subject><ispartof>Vaccine, 2000-10, Vol.19 (4), p.566-571</ispartof><rights>2000 Elsevier Science Ltd</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-d3c20edd38ad507422b328e78aac14f31cbc6e1f9d2d603b998f8c9a6ddfc6bb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=817275$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11027822$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Williamson, E.Diane</creatorcontrib><creatorcontrib>Eley, Steven M.</creatorcontrib><creatorcontrib>Stagg, Anthony J.</creatorcontrib><creatorcontrib>Green, Michael</creatorcontrib><creatorcontrib>Russell, Paul</creatorcontrib><creatorcontrib>Titball, Richard W.</creatorcontrib><title>A single dose sub-unit vaccine protects against pneumonic plague</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>In this study, the protection afforded against aerosolised Yersinia pestis by injection of a single dose of an alhydrogel-adsorbed sub-unit vaccine has been compared with that given by an existing killed whole cell vaccine licensed for human use. The sub-unit vaccine, prepared by admixing F1 antigen derived from a Y. pestis cell culture supernatant with recombinant V antigen derived from an E. coli cell lysate, fully protected an outbred strain of mouse against exposure to 10 6 CFU of virulent plague organisms (10 4 mouse lethal doses, MLD). In contrast, the whole cell vaccine provided only 16% protection against the same level of challenge. Furthermore, sub-unit vaccinees were able to clear the bacteria from their lungs post-challenge whereas bacteria were cultured from the lungs of a surviving KWC vaccinee post-challenge. In killed whole cell vaccinees, physiologically significant levels of IgG to F1 only were detectable and the levels of F1-specific IgG in serum and in broncho-alveolar washings were significantly lower ( p&lt;0.05) compared with sub-unit vaccinees. In sub-unit vaccinees, an IgG titre to the F1 and V antigens was detected in serum where it was significantly higher ( p&lt;0.05) compared with broncho-alveolar washings suggesting that, at the time of challenge, protection is attributable mainly to the combined circulating IgG titre to the F1 and V sub-units. The enhanced protective efficacy of this sub-unit vaccine administered as a single dose compared with an existing vaccine has been demonstrated in an outbred animal model of pneumonic plague.</description><subject>Animals</subject><subject>Antibodies, Bacterial - biosynthesis</subject><subject>Antibodies, Bacterial - blood</subject><subject>Antigens, Bacterial - administration &amp; dosage</subject><subject>Bacterial Proteins - administration &amp; dosage</subject><subject>Bacteriology</subject><subject>Biological and medical sciences</subject><subject>Bronchoalveolar Lavage Fluid - immunology</subject><subject>F1 antigen</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Immunization Schedule</subject><subject>Immunoglobulin G - biosynthesis</subject><subject>Immunoglobulin G - blood</subject><subject>Immunological correlates</subject><subject>Lung - immunology</subject><subject>Lung - microbiology</subject><subject>Mice</subject><subject>Microbiology</subject><subject>Plague - immunology</subject><subject>Plague - microbiology</subject><subject>Plague - prevention &amp; control</subject><subject>Plague Vaccine - administration &amp; dosage</subject><subject>Pneumonic plague</subject><subject>Pore Forming Cytotoxic Proteins</subject><subject>Protection</subject><subject>Single dose vaccine</subject><subject>Spleen - immunology</subject><subject>Sub-unit vaccine</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies</subject><subject>Vaccines, Subunit - administration &amp; dosage</subject><subject>Yersinia pestis</subject><subject>Yersinia pestis - immunology</subject><subject>Yersinia pestis - isolation &amp; purification</subject><subject>Yersinia pestis - pathogenicity</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqF0E1LxDAQgOEgiq4fP0EpCKKH6iRp0_Ski_gFggcVvIV0Ml0i3XRtWsF_b9dd9Ogpl2cmw8vYIYdzDlxdPINQWZpxeDsFOAPgeZmqDTbhupCpyLneZJNfssN2Y3wHgFzycpvtcA6i0EJM2NU0iT7MGkpcGymJQ5UOwffJp0X0gZJF1_aEfUzszPoQ-2QRaJi3wWOyaOxsoH22Vdsm0sH63WOvtzcv1_fp49Pdw_X0McVMQJ86iQLIOamty6HIhKik0FRoa5FnteRYoSJel044BbIqS11rLK1yrkZVVXKPnaz2jhd9DBR7M_cRqWlsoHaIphBSgpblv5AXSmZawAjzFcSujbGj2iw6P7fdl-Fglo3NT2OzDGgAzE9jo8a5o_UHQzUn9ze1jjqC4zWwEW1Tdzagj79O80IU-aguV4rGap-eOhPRU0ByvhuLG9f6fw75BicvmHY</recordid><startdate>20001015</startdate><enddate>20001015</enddate><creator>Williamson, E.Diane</creator><creator>Eley, Steven M.</creator><creator>Stagg, Anthony J.</creator><creator>Green, Michael</creator><creator>Russell, Paul</creator><creator>Titball, Richard W.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T5</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20001015</creationdate><title>A single dose sub-unit vaccine protects against pneumonic plague</title><author>Williamson, E.Diane ; Eley, Steven M. ; Stagg, Anthony J. ; Green, Michael ; Russell, Paul ; Titball, Richard W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-d3c20edd38ad507422b328e78aac14f31cbc6e1f9d2d603b998f8c9a6ddfc6bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Antibodies, Bacterial - biosynthesis</topic><topic>Antibodies, Bacterial - blood</topic><topic>Antigens, Bacterial - administration &amp; dosage</topic><topic>Bacterial Proteins - administration &amp; dosage</topic><topic>Bacteriology</topic><topic>Biological and medical sciences</topic><topic>Bronchoalveolar Lavage Fluid - immunology</topic><topic>F1 antigen</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Immunization Schedule</topic><topic>Immunoglobulin G - biosynthesis</topic><topic>Immunoglobulin G - blood</topic><topic>Immunological correlates</topic><topic>Lung - immunology</topic><topic>Lung - microbiology</topic><topic>Mice</topic><topic>Microbiology</topic><topic>Plague - immunology</topic><topic>Plague - microbiology</topic><topic>Plague - prevention &amp; control</topic><topic>Plague Vaccine - administration &amp; dosage</topic><topic>Pneumonic plague</topic><topic>Pore Forming Cytotoxic Proteins</topic><topic>Protection</topic><topic>Single dose vaccine</topic><topic>Spleen - immunology</topic><topic>Sub-unit vaccine</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies</topic><topic>Vaccines, Subunit - administration &amp; dosage</topic><topic>Yersinia pestis</topic><topic>Yersinia pestis - immunology</topic><topic>Yersinia pestis - isolation &amp; purification</topic><topic>Yersinia pestis - pathogenicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Williamson, E.Diane</creatorcontrib><creatorcontrib>Eley, Steven M.</creatorcontrib><creatorcontrib>Stagg, Anthony J.</creatorcontrib><creatorcontrib>Green, Michael</creatorcontrib><creatorcontrib>Russell, Paul</creatorcontrib><creatorcontrib>Titball, Richard W.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Williamson, E.Diane</au><au>Eley, Steven M.</au><au>Stagg, Anthony J.</au><au>Green, Michael</au><au>Russell, Paul</au><au>Titball, Richard W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A single dose sub-unit vaccine protects against pneumonic plague</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2000-10-15</date><risdate>2000</risdate><volume>19</volume><issue>4</issue><spage>566</spage><epage>571</epage><pages>566-571</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>In this study, the protection afforded against aerosolised Yersinia pestis by injection of a single dose of an alhydrogel-adsorbed sub-unit vaccine has been compared with that given by an existing killed whole cell vaccine licensed for human use. The sub-unit vaccine, prepared by admixing F1 antigen derived from a Y. pestis cell culture supernatant with recombinant V antigen derived from an E. coli cell lysate, fully protected an outbred strain of mouse against exposure to 10 6 CFU of virulent plague organisms (10 4 mouse lethal doses, MLD). In contrast, the whole cell vaccine provided only 16% protection against the same level of challenge. Furthermore, sub-unit vaccinees were able to clear the bacteria from their lungs post-challenge whereas bacteria were cultured from the lungs of a surviving KWC vaccinee post-challenge. In killed whole cell vaccinees, physiologically significant levels of IgG to F1 only were detectable and the levels of F1-specific IgG in serum and in broncho-alveolar washings were significantly lower ( p&lt;0.05) compared with sub-unit vaccinees. In sub-unit vaccinees, an IgG titre to the F1 and V antigens was detected in serum where it was significantly higher ( p&lt;0.05) compared with broncho-alveolar washings suggesting that, at the time of challenge, protection is attributable mainly to the combined circulating IgG titre to the F1 and V sub-units. The enhanced protective efficacy of this sub-unit vaccine administered as a single dose compared with an existing vaccine has been demonstrated in an outbred animal model of pneumonic plague.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>11027822</pmid><doi>10.1016/S0264-410X(00)00159-6</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2000-10, Vol.19 (4), p.566-571
issn 0264-410X
1873-2518
language eng
recordid cdi_proquest_miscellaneous_72330839
source ScienceDirect Freedom Collection 2022-2024
subjects Animals
Antibodies, Bacterial - biosynthesis
Antibodies, Bacterial - blood
Antigens, Bacterial - administration & dosage
Bacterial Proteins - administration & dosage
Bacteriology
Biological and medical sciences
Bronchoalveolar Lavage Fluid - immunology
F1 antigen
Female
Fundamental and applied biological sciences. Psychology
Humans
Immunization Schedule
Immunoglobulin G - biosynthesis
Immunoglobulin G - blood
Immunological correlates
Lung - immunology
Lung - microbiology
Mice
Microbiology
Plague - immunology
Plague - microbiology
Plague - prevention & control
Plague Vaccine - administration & dosage
Pneumonic plague
Pore Forming Cytotoxic Proteins
Protection
Single dose vaccine
Spleen - immunology
Sub-unit vaccine
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies
Vaccines, Subunit - administration & dosage
Yersinia pestis
Yersinia pestis - immunology
Yersinia pestis - isolation & purification
Yersinia pestis - pathogenicity
title A single dose sub-unit vaccine protects against pneumonic plague
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T16%3A06%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20single%20dose%20sub-unit%20vaccine%20protects%20against%20pneumonic%20plague&rft.jtitle=Vaccine&rft.au=Williamson,%20E.Diane&rft.date=2000-10-15&rft.volume=19&rft.issue=4&rft.spage=566&rft.epage=571&rft.pages=566-571&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/S0264-410X(00)00159-6&rft_dat=%3Cproquest_cross%3E72330839%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c420t-d3c20edd38ad507422b328e78aac14f31cbc6e1f9d2d603b998f8c9a6ddfc6bb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17634820&rft_id=info:pmid/11027822&rfr_iscdi=true